In industry news:

Coventry recently announced the release of the fourth part of its 2017 Drug Trends Series, the topicals and specialty medications section. The reports are based on all calendar year transactions billed through its PBM Program, First Script, as well as transactions from medical bill review to reflect the total pharmacy experience for their client base. When releasing the previous parts of its report, Coventry noted that they are continuing to present data for traditional, managed, and unmanaged views; however, they are now sharing the information in shorter, more-condensed pieces delivered every few weeks vs. one large manuscript.

Read Part Four here.

Leave a Comment

Your email address will not be published. Required fields are marked *